PL2201006T3 - Pochodne (R)-4-(heteroarylo)fenyloetylu i zawierające je kompozycje farmaceutyczne - Google Patents

Pochodne (R)-4-(heteroarylo)fenyloetylu i zawierające je kompozycje farmaceutyczne

Info

Publication number
PL2201006T3
PL2201006T3 PL08840589T PL08840589T PL2201006T3 PL 2201006 T3 PL2201006 T3 PL 2201006T3 PL 08840589 T PL08840589 T PL 08840589T PL 08840589 T PL08840589 T PL 08840589T PL 2201006 T3 PL2201006 T3 PL 2201006T3
Authority
PL
Poland
Prior art keywords
useful
treatment
heteroaryl
pharmaceutical compositions
compositions containing
Prior art date
Application number
PL08840589T
Other languages
English (en)
Inventor
Alessio Moriconi
Andrea Aramini
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of PL2201006T3 publication Critical patent/PL2201006T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL08840589T 2007-10-18 2008-10-17 Pochodne (R)-4-(heteroarylo)fenyloetylu i zawierające je kompozycje farmaceutyczne PL2201006T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07020396 2007-10-18
PCT/EP2008/064023 WO2009050258A1 (en) 2007-10-18 2008-10-17 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
EP08840589A EP2201006B1 (en) 2007-10-18 2008-10-17 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
PL2201006T3 true PL2201006T3 (pl) 2011-08-31

Family

ID=40325746

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08840589T PL2201006T3 (pl) 2007-10-18 2008-10-17 Pochodne (R)-4-(heteroarylo)fenyloetylu i zawierające je kompozycje farmaceutyczne

Country Status (18)

Country Link
US (1) US8133911B2 (pl)
EP (1) EP2201006B1 (pl)
JP (1) JP5374511B2 (pl)
CN (1) CN101827841B (pl)
AT (1) ATE501140T1 (pl)
AU (1) AU2008313669B2 (pl)
BR (1) BRPI0817824B8 (pl)
CA (1) CA2702307C (pl)
DE (1) DE602008005488D1 (pl)
DK (1) DK2201006T3 (pl)
ES (1) ES2361233T3 (pl)
HR (1) HRP20110406T1 (pl)
IL (1) IL205029A (pl)
PL (1) PL2201006T3 (pl)
PT (1) PT2201006E (pl)
RU (1) RU2475486C2 (pl)
SI (1) SI2201006T1 (pl)
WO (1) WO2009050258A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
US8271106B2 (en) 2009-04-17 2012-09-18 Hospira, Inc. System and method for configuring a rule set for medical event management and responses
US9594875B2 (en) 2011-10-21 2017-03-14 Hospira, Inc. Medical device update system
US9539383B2 (en) 2014-09-15 2017-01-10 Hospira, Inc. System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein
EP3498269A1 (en) * 2017-12-12 2019-06-19 Dompé farmaceutici S.p.A. C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
US11590057B2 (en) 2020-04-03 2023-02-28 Icu Medical, Inc. Systems, methods, and components for transferring medical fluids
CN115433143B (zh) * 2021-06-03 2023-10-13 中国科学院大连化学物理研究所 一种异噻唑啉酮类化合物的合成方法
EP4397306A1 (en) 2023-01-05 2024-07-10 Dompe' Farmaceutici S.P.A. C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049704A1 (en) * 1996-06-27 1997-12-31 Janssen Pharmaceutica N.V. N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
ITMI20012025A1 (it) * 2001-09-28 2003-03-28 Dompe Spa Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
DK1951663T3 (en) * 2005-11-24 2016-10-10 Dompé Farm S P A (r)-arylkylaminoderivater og farmaceutiske sammensætninger indeholdende dem

Also Published As

Publication number Publication date
JP5374511B2 (ja) 2013-12-25
SI2201006T1 (sl) 2011-07-29
CA2702307A1 (en) 2009-04-23
IL205029A0 (en) 2010-11-30
HRP20110406T1 (hr) 2011-06-30
CN101827841A (zh) 2010-09-08
CN101827841B (zh) 2012-11-28
DE602008005488D1 (de) 2011-04-21
EP2201006B1 (en) 2011-03-09
CA2702307C (en) 2016-04-05
BRPI0817824B1 (pt) 2018-12-26
BRPI0817824A2 (pt) 2015-03-31
AU2008313669A1 (en) 2009-04-23
ES2361233T3 (es) 2011-06-15
AU2008313669B2 (en) 2014-01-16
PT2201006E (pt) 2011-05-05
HK1146723A1 (en) 2011-07-08
US8133911B2 (en) 2012-03-13
EP2201006A1 (en) 2010-06-30
JP2011500643A (ja) 2011-01-06
ATE501140T1 (de) 2011-03-15
US20100249198A1 (en) 2010-09-30
DK2201006T3 (da) 2011-06-27
RU2475486C2 (ru) 2013-02-20
BRPI0817824B8 (pt) 2021-05-25
RU2010119705A (ru) 2011-11-27
WO2009050258A1 (en) 2009-04-23
IL205029A (en) 2014-09-30

Similar Documents

Publication Publication Date Title
IL205029A0 (en) (r)-4-(heteroaryl) phenylpropionic derivatives and pharmaceutical compositions containing them
IL183932A0 (en) 2 - arylpropionic acid derivatives and pharmaceutical compositions contaning them
ATE539063T1 (de) Regioselektive, kupferkatalysierte synthese von benzimidazolen und azabenzimidazolen
MX2011012366A (es) Mezclas fungicidas sinergeticas.
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
NZ593892A (en) Antibiotic compositions for the treatment of gram negative infections
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
WO2005090295A3 (en) 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
PH12013501489A1 (en) Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
WO2007060215A3 (en) (r)-arylkylamino derivatives and pharmaceutical compositions containing them
MX2010006397A (es) Compuestos heterociclicos antivirales.
MX2017008180A (es) Composicion detergente liquida.
IN2014DN01993A (pl)
ATE512157T1 (de) Metallkomplexe
PH12013500695A1 (en) Pharmaceutical compositions containing a dgat1 inhibitor
ATE511501T1 (de) Übergangsmetallkatalysierte synthese von 2h- indazolen
SG11201808171PA (en) Griseofulvin compound
TW200833641A (en) Polyacetylenic compounds
MX2012007539A (es) Derivados de hidroximoil-tetrazol fungicidas.
WO2004080951A3 (en) Sulfonic acids, their derivatives and pharmaceutical compositions containing them
WO2007122792A3 (en) Biofilm formation inhibitor composition
WO2009116044A3 (en) Guanine nucleotide derivatives for treating bacterial infections
MX2012007540A (es) Derivados de hidroximoil-tetrazol fungicidas.
WO2005028425A3 (en) Amidines and derivatives thereof and pharmaceutical compositions containing them
MX345168B (es) Proceso para preparar ranitidina clorhidrato forma 2.